Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
Adhesive Capsulitis, Frozen Shoulder, Shoulder Frozen
About this trial
This is an interventional treatment trial for Adhesive Capsulitis focused on measuring Adhesive Capsulitis, Frozen Shoulder, Shoulder Frozen, Physical Therapy, Corticosteroid Injections, Hydrodilation, Hydro-dilation, Watchful Waiting, Prospective, Glenohumeral Ligament
Eligibility Criteria
Inclusion Criteria:
- Patient must be 18 years or older
- Must meet the following definition for adhesive capsulitis as defined by the American Academy of Orthopedic Surgeons: Self-limiting condition resulting from any inflammatory process about the shoulder in which capsular scar tissue is produced, resulting in pain and limited range of motion; also called frozen shoulder
- Must be amenable to randomization into either cohort
Exclusion Criteria:
- Non-English speaking patients
- Pregnant women (women of childbearing potential will be advised to undergo regular pregnancy testing)
- Patients who had previously undergone operative therapy for the condition
Sites / Locations
- MGH, Massachusetts General HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Physical Therapy with Steroid Injection
Watchful Waiting with Steroid Injection
Patients will undergo regular physical therapy as defined by the standard of care at Massachusetts General Hospital for Adhesive Capsulitis (Frozen Shoulder). If they are in the inflammatory phase of the condition, they will receive 40 mg of depot methylprednisolone in solution with 2 cc of 1% lidocaine.
Patients will undergo no therapeutic intervention outside of steroid injection. If they are in the inflammatory phase of the condition, they will receive 40 mg of depot methylprednisolone in solution with 2 cc of 1% lidocaine.